We wish to inform you that a meeting of the Board of Directors of the Company was held today i.e. 4th February, 2019 transacted the following items of business: ? Financial Results Pursuant to Clause 33 read with Clause 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, please find enclosed herewith the Un-Audited Standalone Financial Results and Limited Review Report for the quarter and nine months ended 31st December, 2018. ? Change in Directorate Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, we wish to inform you that the Board of Directors at its meeting held today i.e 4th February, 2019 have re-appointed Mr. Annaswamy Vaidheesh (DIN No: 01444303) as Managing Director of the Company for period from 1st October, 2019 to 31st March 2020. A Brief profile of Mr. Annaswamy Vaidheesh is enclosed as Annexure.

Pdf Link: Glaxosmithkline Pharmaceuticals Ltd. - Financial Results And Limited Review Report For The Quarter And Nine Months Ended 31St December, 2018.

Source : BSE - www.bseindia.com